# EVOLVING AZIMUTH IN MUSA CONTEXT

Study · id `cardio:ct-nct07022067` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07022067](<https://clinicaltrials.gov/study/NCT07022067>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07022067

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 184 participants.

## Technical summary

Registry record NCT07022067. Randomized; no masking; primary purpose health services research. Start 2024-10-02 (actual); primary completion 2025-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 184 participants (planned count; ClinicalTrials.gov record NCT07022067, source copy `cardio:ctgov-nct07022067-2025-06-15`, retrieved 2026-10-26)
- Started: 2024-10-02 (actual) (ClinicalTrials.gov record NCT07022067, source copy `cardio:ctgov-nct07022067-2025-06-15`, retrieved 2026-10-26)
- Primary completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT07022067, source copy `cardio:ctgov-nct07022067-2025-06-15`, retrieved 2026-10-26)
- Completion: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT07022067, source copy `cardio:ctgov-nct07022067-2025-06-15`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT07022067, source copy `cardio:ctgov-nct07022067-2025-06-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07022067-2025-06-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: EVOLVING AZIMUTH IN MUSA CONTEXT
- Acronym: AZIMUSA
- Condition: Heart Failure
- Condition: Blood Pressure
- Condition: Weight Change
- Condition: Telemonitoring
- Intervention (Device): Telemonitoring app
- Lead sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Lead sponsor class: OTHER
- Collaborator: ASST Grande Ospedale Metropolitano Niguarda
- Collaborator class: OTHER
- Collaborator: University of Milan
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: University of Milan (`cardio:org-university-of-milan`)

## Provenance

Content hash: 1b76bfb5e13af7dcce0e5eea1ee9273a94db40640c87ca9bdc3a55039828fc77
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
